PROCYSBI (Horizon Pharma Inc.)
Welcome to the PulseAid listing for the PROCYSBI drug offered from Horizon Pharma Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Horizon Pharma Inc. |
NON-PROPRIETARY NAME: | Cysteamine bitartrate |
SUBSTANCE NAME: | CYSTEAMINE BITARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE PELLETS |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-04-30 |
END MARKETING DATE: | 0000-00-00 |
PROCYSBI HUMAN PRESCRIPTION DRUG Details:
Item Description | PROCYSBI from Horizon Pharma Inc. |
LABELER NAME: | Horizon Pharma Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 25(mg/1) |
START MARKETING DATE: | 2013-04-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75987-100_4a275d2d-2b7c-49c8-b1ca-68604b962db2 |
PRODUCT NDC: | 75987-100 |
APPLICATION NUMBER: | NDA203389 |
Other CYSTEAMINE BITARTRATE Pharmaceutical Manufacturers / Labelers: